Kun Karnchanapandh

Elucidation of bezlotoxumab binding specificity to toxin B in Clostridioides difficile

T. Rungrotmongkol, Kamonpan Sanachai, Chonnikan Hanpaibool, 2023, Journal of biomolecular structure & dynamics.

Source of oseltamivir resistance due to single E276D, R292K, and double E276D/R292K mutations in H10N4 influenza neuraminidase

T. Rungrotmongkol, Panupong Mahalapbutr, Chonnikan Hanpaibool, 2021 .

Discovery of Novel Naphthoquinone–Chalcone Hybrids as Potent FGFR1 Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling

T. Rungrotmongkol, V. Prachayasittikul, V. Prachayasittikul, 2023, ACS Omega.

BI6727 and GSK461364A, potent PLK1 inhibitors induce G2/M arrest and apoptosis against cholangiocarcinoma cell lines

K. Sawanyawisuth, S. Wongkham, K. Vaeteewoottacharn, 2023, Pathology - Research and Practice.

Enhancing bezlotoxumab binding to C. difficile toxin B2: insights from computational simulations and mutational analyses for antibody design.

T. Rungrotmongkol, R. P. Poo-arporn, Kamonpan Sanachai, 2024, Journal of biomolecular structure & dynamics.